• 1. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 2. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 3. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 4. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 5. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203

• Solvents and Organic Chemicals Organic Compounds Aldehyde/Ketone

Recent Advances in the Study of 2-Chlorocyclododecanone (CAS: 35951-28-1) in Chemical Biology and Pharmaceutical Research

2-Chlorocyclododecanone (CAS: 35951-28-1) is a chlorinated cyclic ketone that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound, characterized by its 12-membered ring structure and reactive chloro and ketone functional groups, serves as a versatile intermediate in the synthesis of complex molecules. Recent studies have explored its utility in drug discovery, material science, and as a building block for bioactive compounds. This research brief aims to summarize the latest findings related to 2-Chlorocyclododecanone, highlighting its synthesis, biological activities, and potential therapeutic applications.

One of the key areas of research involving 2-Chlorocyclododecanone is its role in the synthesis of macrocyclic compounds. Macrocycles are increasingly important in drug discovery due to their ability to bind challenging targets, such as protein-protein interactions. A 2023 study published in the Journal of Medicinal Chemistry demonstrated the use of 2-Chlorocyclododecanone as a precursor in the synthesis of novel macrocyclic kinase inhibitors. The researchers utilized the compound's reactive chloro group to facilitate ring-closing metathesis, yielding potent inhibitors with improved selectivity profiles. This work underscores the compound's value in the development of next-generation therapeutics.

In addition to its synthetic applications, 2-Chlorocyclododecanone has been investigated for its intrinsic biological activities. A recent study in Bioorganic & Medicinal Chemistry Letters reported that derivatives of 2-Chlorocyclododecanone exhibit moderate antimicrobial activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). The researchers proposed that the compound's lipophilic nature and ability to disrupt bacterial cell membranes contribute to this activity. These findings suggest potential applications in the development of new antimicrobial agents, particularly in the face of rising antibiotic resistance.

The pharmacokinetic properties of 2-Chlorocyclododecanone and its derivatives have also been a focus of recent research. A 2024 study in Drug Metabolism and Disposition characterized the metabolic fate of this compound in vitro using human liver microsomes. The study identified several phase I metabolites, including hydroxylated and dechlorinated products, and evaluated their stability and potential toxicity. These insights are crucial for understanding the drug-like properties of 2-Chlorocyclododecanone-based compounds and guiding future structural modifications to improve metabolic stability.

From a materials science perspective, 2-Chlorocyclododecanone has shown promise as a monomer for the synthesis of specialty polymers. Researchers at a leading polymer institute recently reported the development of a new class of cyclododecanone-based polyesters with unique thermal and mechanical properties. The incorporation of 2-Chlorocyclododecanone into the polymer backbone allowed for fine-tuning of the material's crystallinity and degradation profile, making it potentially useful for biomedical applications such as controlled drug delivery systems.

Looking forward, the diverse applications of 2-Chlorocyclododecanone (CAS: 35951-28-1) continue to expand across chemical biology and pharmaceutical research. Current challenges include optimizing its synthetic accessibility and further exploring structure-activity relationships among its derivatives. With ongoing advances in synthetic methodology and biological evaluation, this compound is poised to play an increasingly important role in the development of novel therapeutic agents and functional materials. Future research directions may include its application in targeted drug delivery systems, as a scaffold for PROTACs (proteolysis targeting chimeras), or as a component of supramolecular assemblies for biomedical applications.

• 104233-56-9(2,7-Nonanedione, 6-chloro-)
• 77527-88-9(3-Octanone, 4-chloro-)
• 61295-53-2(5-Nonanone, 4-chloro-)
• 66241-39-2(3-Octanone, 2-chloro-)
• 84098-60-2(2-Hexanone,3,6-dichloro-)
• 24251-77-2(2-Octanone, 3-chloro-)
• 19995-88-1(2,6-Heptanedione,3-chloro-)
• 4828-34-6(2-chlorocyclooctanone)
• 766-66-5(2-chlorocycloheptan-1-one)
• 61295-52-1(4-Heptanone, 3-chloro-)